CV Sciences, Inc. has entered into a new secured financing agreement with an institutional investor, issuing a promissory note with an original principal amount of $600,000. The transaction, which closed on October 7, 2025, involved an original issuance discount of $150,000 and an additional $150,000 payment related to a modification of a previous agreement, resulting in net proceeds of $300,000 for the company. The note, due on April 6, 2027, requires monthly repayments starting April 6, 2026, and is secured by all company and subsidiary assets, including intellectual property. No interest will accrue unless there is an event of default, and early repayment within six months offers an 8% discount on the outstanding balance.